Saw Sonia, Thomas Nick, Gleeson Michael J, Bódi István, Connor Steve, Hortobágyi Tibor
Department of Clinical Neuropathology, King's College Hospital, London, UK.
Pathol Oncol Res. 2009 Jun;15(2):291-5. doi: 10.1007/s12253-008-9124-y. Epub 2008 Nov 15.
Giant cell tumour (GCT) of bone is an uncommon primary bone neoplasm typically occurring at the epiphyses of long bones in young adults. They are osteolytic neoplasms with approximate local recurrence rates of 25%, and 2% of patients develop pulmonary metastases. These tumours appear very rarely in the skull, with those few reported cases arising predominantly in the sphenoid and occasionally the temporal bones. They demonstrate benign histological features, but are locally aggressive and surgical excision is the treatment of choice. It is widely believed that giant cell tumours should be distinguished from other giant cell lesions, importantly central giant cell reparative granulomata (CGCG) which are thought to have a lower recurrence rate and for which no cases of malignant transformation or metastases have been reported. Investigators have noted that giant cell lesions in the skull bones may be unique and that GCT and CGCG may be part of a spectrum of a single disease process. We present a case of a giant cell tumour of the temporal bone which illustrates and re-emphasises this concept and review the literature on these lesions.
骨巨细胞瘤(GCT)是一种少见的原发性骨肿瘤,通常发生于年轻成人长骨的骨骺部位。它们是溶骨性肿瘤,局部复发率约为25%,2%的患者会发生肺转移。这些肿瘤极少出现在颅骨,少数报道病例主要发生在蝶骨,偶尔见于颞骨。它们表现出良性组织学特征,但具有局部侵袭性,手术切除是首选治疗方法。人们普遍认为,骨巨细胞瘤应与其他巨细胞病变相鉴别,尤其是中央型巨细胞修复性肉芽肿(CGCG),后者被认为复发率较低,且未报道有恶变或转移病例。研究人员指出,颅骨的巨细胞病变可能具有独特性,骨巨细胞瘤和中央型巨细胞修复性肉芽肿可能是单一疾病过程的不同表现形式。我们报告一例颞骨巨细胞瘤病例,该病例阐释并再次强调了这一概念,并对这些病变的相关文献进行了综述。